Irish health technology company Alltracel said today year-to-date revenues are line with expectations.
The company said strong shipments in continental Europe in both its private label and proprietary wound care brands produced third-quarter revenues of €5 million.
Total revenue so far this year has reached €13.4 million. Chief executive Tony Richardson said he remains comfortable with a year-end revenue figure of €21 million.
Alltracel shares, which trade in Dublin and London's AIM market, rose 3/4p to 15-1/4p after the trading statement.
